Which has the lower trailing P/E, ABBV or TMO?

TMO has the lower trailing P/E: ABBV trades at 72.43 and TMO at 32.80. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or TMO?

Over the past five years, TMO grew revenue faster — ABBV at a 3.69% CAGR versus TMO at 5.00%.

Does ABBV or TMO pay a bigger dividend?

ABBV yields 2.68% and TMO yields 0.30% based on trailing dividends and the latest price.

Is ABBV or TMO more profitable?

TMO runs the higher net margin — ABBV at 9.81% versus TMO at 15.06%.

How have ABBV and TMO total returns compared?

Over the past 10 years, ABBV delivered 19.76% and TMO delivered 15.81% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Thermo Fisher Scientific Inc. (TMO)

A side-by-side comparison of AbbVie Inc. and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

TMO

Thermo Fisher Scientific Inc.

$226.62B

$609.82HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs TMO

growth of $100 · dividends reinvested · last 10y

ABBV +497.3% (+19.6%/yr)TMO +312.7% (+15.2%/yr)ABBV compounded faster over this window

ABBV TMO

ABBV vs TMO: by the numbers

•ABBV is the larger company ($454.17B vs $226.62B market cap).
•TMO trades at the lower trailing earnings multiple (32.80 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•TMO converts more revenue to profit (15.06% vs 9.81% net margin).
•TMO grew revenue faster over the past five years (5.00% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 0.30%).

Metrics side by side

Valuation

Metric	ABBV	TMO
P/E ratio	72.43	32.80
Forward P/E	18.32	24.29
P/S ratio	7.05	4.89
P/B ratio	N/A	4.30
EV / EBITDA	19.34	25.25
FCF yield	3.99%	3.23%

Profitability

Metric	ABBV	TMO
Gross margin	71.48%	40.37%
Operating margin	29.32%	17.69%
Net margin	9.81%	15.06%
ROE	N/A	13.25%
ROIC	13.46%	7.44%

Dividends

Metric	ABBV	TMO
Dividend yield	2.68%	0.30%
Payout ratio	192.43%	9.68%

Growth (annualized)

Metric	ABBV	TMO
Revenue CAGR (5Y)	3.69%	5.00%
EPS CAGR (5Y)	-2.79%	1.99%
FCF CAGR (5Y)	0.11%	-1.83%
Total return CAGR (5Y)	23.51%	1.55%

Frequently asked

Which has the lower trailing P/E, ABBV or TMO?: TMO has the lower trailing P/E: ABBV trades at 72.43 and TMO at 32.80. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or TMO?: Over the past five years, TMO grew revenue faster — ABBV at a 3.69% CAGR versus TMO at 5.00%.
Does ABBV or TMO pay a bigger dividend?: ABBV yields 2.68% and TMO yields 0.30% based on trailing dividends and the latest price.
Is ABBV or TMO more profitable?: TMO runs the higher net margin — ABBV at 9.81% versus TMO at 15.06%.
How have ABBV and TMO total returns compared?: Over the past 10 years, ABBV delivered 19.76% and TMO delivered 15.81% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Thermo Fisher Scientific P/E ratio AbbVie dividend yield Thermo Fisher Scientific dividend yield AbbVie ROE Thermo Fisher Scientific ROE AbbVie operating margin Thermo Fisher Scientific operating margin AbbVie revenue growth Thermo Fisher Scientific revenue growth AbbVie free cash flow Thermo Fisher Scientific free cash flow

AbbVie & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest 10-Year Total Return Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.